NEWM&A

Sun Pharma (SUN) Acquires Organon for $11.75 Billion

Published on 4/27/2026

#SUN#M&A#Healthcare#Pharmaceuticals
Sun Pharma (SUN) Acquires Organon for $11.75 Billion

AI Summary

Sun Pharma (SUN) has announced its acquisition of U.S. healthcare firm Organon for $11.75 billion. This deal marks a significant expansion for Sun Pharma, aiming to strengthen its position in the global pharmaceutical market. The acquisition could impact market dynamics as it reflects ongoing consolidation in the healthcare sector. Investors will be monitoring how this transaction influences both companies' stock performances following the announcement.

Source: Read original article (opens in new tab)

Related News

Sun Pharma (SUN) Acquires Organon for $11.75 Billion in Cash
M&A

Sun Pharma (SUN) Acquires Organon for $11.75 Billion in Cash

Apr 27

Atlas Arteria (ALX) Receives $4.9B Takeover Bid from IFM Investors
M&A

Atlas Arteria (ALX) Receives $4.9B Takeover Bid from IFM Investors

Apr 26

Mayville Engineering (MEC) Shareholders Elect Board Until 2029
M&A

Mayville Engineering (MEC) Shareholders Elect Board Until 2029

Apr 26

Eli Lilly (LLY) Plans $7B Acquisition, P/E at 40 Amid Growth
M&A

Eli Lilly (LLY) Plans $7B Acquisition, P/E at 40 Amid Growth

Apr 25